UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

Stocks Yahoo Finance By Yahoo Finance 19 May 2026 16:24 1 min read

UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.